Article
Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses
26 Apr 2021
Abstract excerpt
Type I interferons (IFNs) are our first line of defense against virus infection. Recent studies have suggested the ability of SARS-CoV-2 proteins to inhibit IFN responses. Emerging data also suggest that timing and extent of IFN production is associated with manifestation of COVID-19 severity. In spite of progress in understanding how SARS-CoV-2 activates antiviral responses, mechanistic studies into wild-type...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
